Daniel Cohen is an Infectious Disease physician. ClinicalTrials.gov lists 5 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
7 Haviland St
Boston, MA 021152683
Telephone
617-927-6100Registry record last updated 13 Jul 2007.
Clinical trials
- Evaluation of Ingenol Mebutate for Actinic Cheilitis Treatment
Sponsor: Instituto Nacional de Cancer, Brazil
- Identification of Correlates of Protection Against Shigella and Enterotoxigenic Escherichia Coli Infections
Sponsor: Hillel Yaffe Medical Center
- ABT-450 With Ritonavir and ABT-267 and/or ABT-333 With and Without Ribavirin in Genotype 1 Hepatitis C Virus Infected Patients
Sponsor: AbbVie (prior sponsor, Abbott)
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Astellas Pharma US IncProgram year20251 payment
- Astellas Pharma US IncProgram year20231 payment
- Astellas Pharma US IncProgram year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
2 NIH research awards on record, funded 1993–2015 per NIH RePORTER. The latest:
- Development of New Metal_Catalyzed Hydroacylation and Hydroarylation Processes
Massachusetts Institute of Technology
FY2015$54,194F32GM108294 - Development of New Metal_Catalyzed Hydroacylation and Hydroarylation Processes
Massachusetts Institute of Technology
FY2014$51,530F32GM108294 - Development of New Metal_Catalyzed Hydroacylation and Hydroarylation Processes
Massachusetts Institute of Technology
FY2013$47,114F32GM108294
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Yousef Khader
Jordan University of Science and Technology
Andrew Rambaut
University of Edinburgh
Olayinka Stephen Ilesanmi
University College Hospital
Maysaa El Sayed Zaki
Mansoura University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”